Literature DB >> 9185522

Differential screening of a human chromosome 3 library identifies hepatocyte growth factor-like/macrophage-stimulating protein and its receptor in injured lung. Possible implications for neuroendocrine cell survival.

C G Willett1, D I Smith, V Shridhar, M H Wang, R L Emanuel, K Patidar, S A Graham, F Zhang, V Hatch, D J Sugarbaker, M E Sunday.   

Abstract

Transient pulmonary neuroendocrine cell hyperplasia and non-neuroendocrine lung tumors develop in nitrosaminetreated hamsters, which we hypothesized might modulate epithelial cell phenotype by expressing gene(s) homologous to human chromosome 3p gene(s) deleted in small cell carcinoma of the lung (SCLC). We differentially screened a chromosome 3 library using nitrosamine-treated versus normal hamster lung cDNAs and identified hepatocyte growth factor-like/macrophage-stimulating protein (HGFL/MSP) in injured lung. HGFL/MSP mRNA is low to undetectable in human SCLC and carcinoid tumors, but the HGFL/MSP tyrosine kinase receptor, RON, is present and functional on many of these neuroendocrine tumors. In H835, a pulmonary carcinoid cell line, and H187, a SCLC cell line, HGFL/ MSP induced adhesion/flattening and apoptosis. Using viable cell counts to assess proliferation after 14 d of treatment with HGFL/MSP, there is growth inhibition of H835 but not H187. Nitrosamine-treated hamsters also demonstrate pulmonary neuroendocrine cell apoptosis in situ during the same time period as expression of the endogenous HGFL/ MSP gene, immediately preceding the spontaneous regression of neuroendocrine cell hyperplasia. These observations suggest that HGFL/MSP might regulate neuroendocrine cell survival during preneoplastic lung injury, which could influence the ultimate tumor cell phenotype.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9185522      PMCID: PMC508150          DOI: 10.1172/JCI119493

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

Review 1.  Determination of biomarkers for intermediate end points in chemoprevention trials.

Authors:  J S Lee; S M Lippman; W K Hong; J Y Ro; S Y Kim; R Lotan; W N Hittelman
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

2.  Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung.

Authors:  H Brauch; B Johnson; J Hovis; T Yano; A Gazdar; O S Pettengill; S Graziano; G D Sorenson; B J Poiesz; J Minna
Journal:  N Engl J Med       Date:  1987-10-29       Impact factor: 91.245

3.  Restriction fragment length polymorphism studies show consistent loss of chromosome 3p alleles in small cell lung cancer patients' tumors.

Authors:  B E Johnson; A Y Sakaguchi; A F Gazdar; J D Minna; D Burch; A Marshall; S L Naylor
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

Review 4.  Transcription factors and recessive oncogenes in the pathogenesis of human lung cancer.

Authors:  J D Minna; J Schütte; J Viallet; F Thomas; F J Kaye; T Takahashi; M Nau; J Whang-Peng; M Birrer; A F Gazdar
Journal:  Int J Cancer Suppl       Date:  1989

5.  Clonal origin of columnar, mucous, and endocrine cell lineages in human colorectal epithelium.

Authors:  S C Kirkland
Journal:  Cancer       Date:  1988-04-01       Impact factor: 6.860

6.  Saturation of human chromosome 3 with unique sequence hybridization probes.

Authors:  D I Smith; R Mangrulker; R Geist; J Gilbert; K Kinsman; H Drabkin; W Golembieski
Journal:  Genomics       Date:  1989-05       Impact factor: 5.736

7.  Oat-cell carcinoma of the lung. Its origin and relationship to bronchial carcinoid.

Authors:  K G Bensch; B Corrin; R Pariente; H Spencer
Journal:  Cancer       Date:  1968-12       Impact factor: 6.860

8.  Establishment and identification of small cell lung cancer cell lines having classic and variant features.

Authors:  D N Carney; A F Gazdar; G Bepler; J G Guccion; P J Marangos; T W Moody; M H Zweig; J D Minna
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

9.  Lung carcinoid cell lines have bombesin-like peptides and EGF receptors.

Authors:  T W Moody; M Lee; R M Kris; F Bellot; G Bepler; H Oie; A F Gazdar
Journal:  J Cell Biochem       Date:  1990-06       Impact factor: 4.429

10.  Lack of expression of aminoacylase-1 in small cell lung cancer. Evidence for inactivation of genes encoded by chromosome 3p.

Authors:  Y E Miller; J D Minna; A F Gazdar
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

View more
  8 in total

1.  The Ron/STK receptor tyrosine kinase is essential for peri-implantation development in the mouse.

Authors:  R S Muraoka; W Y Sun; M C Colbert; S E Waltz; D P Witte; J L Degen; S J Friezner Degen
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Macrophage-stimulating protein differently affects human alveolar macrophages from smoker and non-smoker patients: evaluation of respiratory burst, cytokine release and NF-kappaB pathway.

Authors:  Gabriele Gunella; Claudio Bardelli; Angela Amoruso; Ilario Viano; Piero Balbo; Sandra Brunelleschi
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

Review 3.  Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.

Authors:  Omid Zarei; Silvia Benvenuti; Fulya Ustun-Alkan; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-08       Impact factor: 4.553

4.  Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice.

Authors:  J A Bezerra; T L Carrick; J L Degen; D Witte; S J Degen
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

5.  Identification of a RON tyrosine kinase receptor binding peptide using phage display technique and computational modeling of its binding mode.

Authors:  Omid Zarei; Silvia Benvenuti; Fulya Ustun-Alkan; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal:  J Mol Model       Date:  2017-08-19       Impact factor: 1.810

Review 6.  MSP-RON signalling in cancer: pathogenesis and therapeutic potential.

Authors:  Hang-Ping Yao; Yong-Qing Zhou; Ruiwen Zhang; Ming-Hai Wang
Journal:  Nat Rev Cancer       Date:  2013-07       Impact factor: 60.716

Review 7.  Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.

Authors:  Purnima K Wagh; Belinda E Peace; Susan E Waltz
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

8.  Expression of Hepatocyte Growth Factor-Like Protein in Human Wound Tissue and Its Biological Functionality in Human Keratinocytes.

Authors:  James C Glasbey; Andrew J Sanders; David C Bosanquet; Fiona Ruge; Keith G Harding; Wen G Jiang
Journal:  Biomedicines       Date:  2015-02-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.